首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1741039

透析器市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Dialyzers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年04月29日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球透析器市場價值為 55 億美元，預計到 2034 年將以 6.6% 的複合年成長率成長至 104 億美元。這一成長是由家庭血液透析 (HHD) 解決方案需求的不斷成長、急性腎損傷發病率的不斷上升以及透析器技術的持續創新所驅動。隨著越來越多的患者尋求靈活且高效的治療方案，高性能透析器的採用正在顯著增加。具有增強生物相容性的合成膜已成為關鍵關注點，因為它們提高了廢物清除效率並減少了每次透析所需的時間。這些膜是透過聚合物科學和奈米技術的進步而開發出來的，具有更高的機械強度、更強的過濾性以及對蛋白質積聚和細菌生長的抵抗力。向更好材料的轉變不僅改善了臨床結果，而且還使透析程序對長期患者更安全、更耐受。此外，輕巧、可攜式透析機的趨勢刺激了對緊湊、高效透析器的需求，尤其是對於選擇居家護理的患者而言。

高通量透析器因其能夠清除較大分子（例如B2微球蛋白）而日益普及，提升患者舒適度並縮短治療時間。預計該領域將實現顯著成長，到2034年將達到72億美元以上，複合年成長率為6.8%。由於其先進的過濾能力以及與現代透析設備的兼容性，醫療保健提供者越來越青睞這些透析器。這些產品中使用的合成膜通常塗有抗凝血劑，有助於減少治療併發症。合成材料也不太可能引發免疫反應，使其成為長期使用的理想選擇。因此，合成透析器領域在2024年以49億美元的價值佔據市場主導地位，預計2034年將成長到94億美元以上。它們較低的免疫原性和對感染性生物膜的抵抗力使其成為優於纖維素基透析器的首選。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	55億美元
預測值	104億美元
複合年成長率	6.6%

一次性透析器是另一個發展勢頭強勁的細分市場。這些一次性設備在2024年的市場規模為31億美元，預計到2034年將達到57億美元。隨著對感染控制的日益重視，尤其是在新冠疫情之後，人們明顯轉向使用一次性透析器。這些透析器無需清潔和消毒，無論是在臨床或家庭環境中都更容易使用。它們對於免疫系統受損或患有慢性疾病的患者尤其有利，因為它們可以降低交叉污染的風險。保險覆蓋範圍的擴大和病患照護模式的不斷發展，進一步支持了一次性透析器的普及。

中心透析市場仍佔據主導地位，2024 年市佔率達 69.3%，預計到 2034 年將超過 70 億美元。慢性病患者數量不斷增加，尤其是在老年人口中，推動了對中心治療的需求。這些機構為有複雜醫療需求的患者提供必要的專業護理和監督。在居家透析尚未普及的地區，中心照護仍是唯一可行的選擇。隨著全球生活方式相關疾病的發生率持續上升，越來越多的透析診所和治療中心正在建立，以滿足日益成長的患者需求。

北美引領透析器市場，其驅動力源自於末期腎病 (ESRD) 的高發生率、強大的醫療基礎設施以及家用透析系統的普及。 2024 年，光是美國就達到了 22 億美元，預計到 2034 年將以 5.5% 的複合年成長率成長。歐洲緊隨其後，其老年人口不斷增加，且擁有完善的報銷體系，支持中心內治療。在亞太地區，由於人們意識的提高、醫療保健管道的拓展以及糖尿病患者的不斷成長，尤其是在擁有大片農村地區並開始獲得現代透析服務的國家，該地區的成長正在加速。

透析器市場的競爭格局由許多全球主要參與者的強勢存在決定，這些參與者專注於創新、建立策略夥伴關係並拓展服務範圍。排名前三的公司佔據了約60%的市場佔有率，反映出該行業的整合和競爭態勢。這些製造商正在大力投資研發生物相容性薄膜和智慧連網設備，以提升效能和使用者體驗。一些公司正在調整其產品組合，以滿足中心和家庭透析治療的需求，同時推出環境永續的解決方案。他們正在利用與醫療保健提供者、醫院和透析網路的策略合作來擴大全球影響力並加強分銷。

產業生態系統分析
產業衝擊力
- 成長動力
  - 全球慢性腎臟病盛行率不斷上升
  - 透析器技術進步
  - 居家透析治療的需求不斷成長
- 產業陷阱與挑戰
  - 治療費用高
  - 透析治療相關併發症的風險
成長潛力分析
監管格局
川普政府關稅
- 對貿易的影響
  - 貿易量中斷
  - 各國應對措施
- 對產業的影響
  - 供應方影響（製造成本）
    - 主要材料價格波動
    - 供應鏈重組
    - 生產成本影響
  - 需求面影響（消費者成本）
    - 價格傳導至終端市場
    - 市佔率動態
    - 消費者反應模式
- 受影響的主要公司
- 策略產業反應
  - 供應鏈重組
  - 定價和產品策略
  - 政策參與
- 展望與未來考慮
定價分析
技術格局
差距分析
波特的分析
PESTEL分析
價值鏈分析

第4章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第5章：市場估計與預測：按類型，2021 - 2034 年

主要趨勢
高通量透析器
低通量透析器

第6章：市場估計與預測：按材料，2021 - 2034 年

主要趨勢
合成的
纖維素基

第7章：市場估計與預測：按用途，2021 - 2034 年

主要趨勢
一次性的
可重複使用的

第8章：市場估計與預測：依最終用途，2021 - 2034 年

主要趨勢
中心
居家透析

第9章：市場估計與預測：按地區，2021 - 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第10章：公司簡介

Allmed
ASAHI KASEI MEDICAL
B. Braun
Baxter
Dialife
Farmasol
Fresenius
JMS
Medica
Medtronic
NIKKISO
NIPRO
SB KAWASUMI
TORAY
WESLEY

簡介目錄

Product Code: 4684

The Global Dialyzers Market was valued at USD 5.5 billion in 2024 and is estimated to grow at a CAGR of 6.6% to reach USD 10.4 billion by 2034. This expansion is driven by rising demand for home-based hemodialysis (HHD) solutions, a growing prevalence of acute kidney injuries, and ongoing innovation in dialyzer technology. As more patients seek flexible and efficient treatment options, the adoption of high-performance dialyzers is increasing significantly. Synthetic membranes with enhanced biocompatibility have become a crucial focus, as they improve waste removal efficiency and reduce the time required per dialysis session. These membranes, developed through advancements in polymer science and nanotechnology, offer improved mechanical strength, enhanced filtration, and resistance to protein build-up and bacterial growth. The shift toward better materials is not only improving clinical outcomes but also making dialysis procedures safer and more tolerable for long-term patients. In addition, the trend toward lightweight and portable dialysis machines has fueled demand for compact, high-efficiency dialyzers, especially among patients opting for home-based care.

High-flux dialyzers are gaining popularity due to their ability to eliminate larger molecules such as B2--microglobulin, which enhances patient comfort and shortens treatment times. This segment is expected to witness notable growth, reaching over USD 7.2 billion by 2034, with a CAGR of 6.8%. Healthcare providers increasingly favor these dialyzers due to their advanced filtration capabilities and compatibility with modern dialysis equipment. The use of synthetic membranes in these products, often coated with anticoagulants, is helping reduce treatment complications. Synthetic materials are also less likely to trigger immune responses, making them ideal for long-term use. As a result, the synthetic dialyzer segment dominated the market with a value of USD 4.9 billion in 2024 and is projected to grow to more than USD 9.4 billion by 2034. Their lower immunogenicity and resistance to infection-causing biofilms make them preferable over cellulose-based options.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$5.5 Billion
Forecast Value	$10.4 Billion
CAGR	6.6%

Disposable dialyzers are another segment witnessing significant momentum. These single-use devices accounted for USD 3.1 billion in 2024 and are expected to reach USD 5.7 billion by 2034. With growing emphasis on infection control, particularly in the aftermath of the COVID-19 pandemic, there has been a noticeable shift toward disposable options. These dialyzers eliminate the need for cleaning and sterilization, making them easier to use in both clinical and home settings. They are especially advantageous for patients with compromised immune systems or chronic conditions, as they reduce cross-contamination risks. Enhanced insurance coverage and evolving patient care models further support the adoption of disposable dialyzers.

The in-center dialysis segment remains dominant, holding a market share of 69.3% in 2024 and expected to surpass USD 7 billion by 2034. The increasing number of patients with chronic diseases, especially in the aging population, drives demand for in-center treatments. These facilities offer the specialized care and supervision necessary for individuals with complex medical needs. In regions where home dialysis is not widely available, in-center care remains the only viable option. As lifestyle-related illnesses continue to rise globally, more dialysis clinics and treatment centers are being established to meet growing patient needs.

North America leads the dialyzers market, driven by a high prevalence of end-stage renal disease (ESRD), strong healthcare infrastructure, and increased adoption of home dialysis systems. In 2024, the U.S. alone accounted for USD 2.2 billion and is projected to grow at a CAGR of 5.5% through 2034. Europe follows closely, with rising elderly populations and well-established reimbursement systems supporting in-center treatments. In the Asia Pacific region, growth is accelerating due to increasing awareness, expanding healthcare access, and a growing diabetic population, particularly in countries with large rural areas now gaining access to modern dialysis services.

The competitive landscape of the dialyzers market is defined by the strong presence of key global players that prioritize innovation, strategic partnerships, and expanded service offerings. The top three companies hold around 60% of the total market share, reflecting a consolidated and competitive industry. These manufacturers are investing significantly in R&D to develop biocompatible membranes and smart-connected devices that improve performance and user experience. Several companies are aligning their portfolios to cater to both in-center and home-based dialysis treatments, while also introducing environmentally sustainable solutions. Strategic collaborations with healthcare providers, hospitals, and dialysis networks are being used to expand global reach and strengthen distribution.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic kidney diseases globally
  - 3.2.1.2 Technological advancements in dialyzer technology
  - 3.2.1.3 Rising demand for home dialysis therapies treatments
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High treatment cost
  - 3.2.2.2 Risk of complications associated with dialysis treatments
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Trump administration tariffs
- 3.5.1 Impact on trade
  - 3.5.1.1 Trade volume disruptions
  - 3.5.1.2 Country-wise response
- 3.5.2 Impact on the industry
  - 3.5.2.1 Supply-side impact (Cost of manufacturing)
    - 3.5.2.1.1 Price volatility in key materials
    - 3.5.2.1.2 Supply chain restructuring
    - 3.5.2.1.3 Production cost implications
  - 3.5.2.2 Demand-side impact (Cost to consumers)
    - 3.5.2.2.1 Price transmission to end markets
    - 3.5.2.2.2 Market share dynamics
    - 3.5.2.2.3 Consumer response patterns
- 3.5.3 Key companies impacted
- 3.5.4 Strategic industry responses
  - 3.5.4.1 Supply chain reconfiguration
  - 3.5.4.2 Pricing and product strategies
  - 3.5.4.3 Policy engagement
- 3.5.5 Outlook and future considerations
3.6 Pricing analysis
3.7 Technology landscape
3.8 Gap analysis
3.9 Porter's analysis
3.10 PESTEL analysis
3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 High-flux dialyzers
5.3 Low-flux dialyzers

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Synthetic
6.3 Cellulose-based

Chapter 7 Market Estimates and Forecast, By Usage, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 Disposable
7.3 Reusable

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

8.1 Key trends
8.2 In-center
8.3 Home dialysis

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE